Synthesis and anticancer activities of 6-amino amonafide derivatives
@article{Norton2008SynthesisAA, title={Synthesis and anticancer activities of 6-amino amonafide derivatives}, author={John T Norton and Mark A. Witschi and L. Luong and A. Kawamura and S. Ghosh and M. Sharon Stack and E. Sim and M. Avram and D. Appella and S. Huang}, journal={Anti-Cancer Drugs}, year={2008}, volume={19}, pages={23-36} }
Amonafide is a DNA intercalator and topoisomerase II inhibitor in clinical development for the treatment of neoplastic diseases. Amonafide contains a free arylamine, which causes it to be metabolized in humans by N-acetyl transferase-2 (NAT2) into a toxic form. To eliminate the NAT2 acetylation of amonafide while retaining the anticancer properties, we have synthesized nine derivatives that are structurally similar to amonafide that should not be acetylated. Eight derivatives have arylamines at… CONTINUE READING
Topics from this paper
38 Citations
Synthesis, cytotoxicity, DNA binding and topoisomerase II inhibition of cassiarin A derivatives.
- Chemistry, Medicine
- Bioorganic & medicinal chemistry letters
- 2014
- 9
Is an Efficacious and Minimally Toxic Amonafide Derivative in Murine Models of Human Cancer 1
- Biology
- 2011
Synthesis and evaluation of novel amonafide–polyamine conjugates as anticancer agents
- Chemistry, Medicine
- Chemical biology & drug design
- 2017
- 5
Anticancer Activity and Topoisomerase II Inhibition of Naphthalimides with ω-Hydroxylalkylamine Side-Chains of Different Lengths.
- Chemistry, Medicine
- Medicinal chemistry (Shariqah (United Arab Emirates))
- 2018
Evaluation of apoptotic effect of cyclic imide derivatives on murine B16F10 melanoma cells.
- Chemistry, Medicine
- Bioorganic & medicinal chemistry
- 2011
- 21
Methoxyethylamino-numonafide is an efficacious and minimally toxic amonafide derivative in murine models of human cancer.
- Biology, Medicine
- Neoplasia
- 2011
- 15
- PDF
Induction of apoptosis and suppression of ERCC1 expression by the potent amonafide analogue 8-c in human colorectal carcinoma cells
- Chemistry, Medicine
- Anti-cancer drugs
- 2013
- 5
Novel naphthalimide derivatives as potential apoptosis-inducing agents: design, synthesis and biological evaluation.
- Chemistry, Medicine
- European journal of medicinal chemistry
- 2009
- 31
Synthesis, anticancer activity and DNA-binding properties of novel 4-pyrazolyl-1,8-naphthalimide derivatives.
- Chemistry, Medicine
- Bioorganic & medicinal chemistry letters
- 2014
- 26
References
SHOWING 1-10 OF 30 REFERENCES
Pharmacogenetics of anticancer agents: lessons from amonafide and irinotecan.
- Biology, Medicine
- Drug metabolism and disposition: the biological fate of chemicals
- 2001
- 89
- PDF
Eukaryotic arylamine N-acetyltransferase. Investigation of substrate specificity by high-throughput screening.
- Biology, Medicine
- Biochemical pharmacology
- 2005
- 94
New analogues of amonafide and elinafide, containing aromatic heterocycles: synthesis, antitumor activity, molecular modeling, and DNA binding properties.
- Medicine, Chemistry
- Journal of medicinal chemistry
- 2004
- 97
Pharmacokinetics and metabolism of the antitumor drug amonafide (NSC-308847) in humans.
- Chemistry, Medicine
- Drug metabolism and disposition: the biological fate of chemicals
- 1987
- 34
In vitro toxicity and DNA cleaving capacity of benzisoquinolinedione (nafidimide; NSC 308847) in human leukemia.
- Biology, Chemistry
- Cancer research
- 1987
- 33
Topoisomerase II-mediated DNA cleavage by amonafide and its structural analogs.
- Biology, Medicine
- Molecular pharmacology
- 1989
- 89
In vitro cytotoxicity and DNA damage production in Chinese hamster ovary cells and topoisomerase II inhibition by 2-[2'- (dimethylamino)ethyl]-1,2-dihydro-3H-dibenz[ de,h]isoquinoline-1,3-diones with substitutions at the 6 and 7 positions (azonafides)
- Biology, Medicine
- Anti-cancer drugs
- 1997
- 13
Base sequence determinants of amonafide stimulation of topoisomerase II DNA cleavage.
- Biology, Medicine
- Nucleic acids research
- 1995
- 33
Amonafide: An active agent in the treatment of previously untreated advanced breast cancer--a cancer and leukemia group B study (CALGB 8642).
- Medicine
- Clinical cancer research : an official journal of the American Association for Cancer Research
- 1995
- 41
- PDF
ATP-bound Topoisomerase II as a Target for Antitumor Drugs*
- Medicine, Biology
- The Journal of Biological Chemistry
- 2001
- 53
- PDF